Brown Brothers Harriman & Co’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Brown Brothers Harriman & Co’s Portfolio MITO Stock Details MITO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-174,999	Closed	-$54K	–	1569
2022 Q3	$54K	Hold	174,999	–	–	﹤0.01%	725
2022 Q2	$44K	Hold	174,999	–	–	﹤0.01%	733
2022 Q1	$123K	Hold	174,999	–	–	﹤0.01%	597
2021 Q4	$145K	Hold	174,999	–	–	﹤0.01%	536
2021 Q3	$238K	Hold	174,999	–	–	﹤0.01%	421
2021 Q2	$273K	Hold	174,999	–	–	﹤0.01%	386
2021 Q1	$275K	Hold	174,999	–	–	﹤0.01%	360
2020 Q4	$262K	Hold	174,999	–	–	﹤0.01%	392
2020 Q3	$236K	Hold	174,999	–	–	﹤0.01%	359
2020 Q2	$320K	Hold	174,999	–	–	﹤0.01%	312
2020 Q1	$217K	Hold	174,999	–	–	﹤0.01%	340
2019 Q4	$570K	Buy	+174,999	New	+$1.34M	﹤0.01%	288

Brown Brothers Harriman & Co's MITO Position: Q4 2022 in Review

Brown Brothers Harriman & Co sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 174,999 shares — an estimated $54K sold.

Brown Brothers Harriman & Co first reported a position in MITO in Q4 2019 and held it in 12 quarters. The position peaked at $570K in Q4 2019. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

Brown Brothers Harriman & Co reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
Brown Brothers Harriman & Co sold 174,999 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $54K.
Brown Brothers Harriman & Co first reported a position in Stealth BioTherapeutics Corp. ADS in Q4 2019 and held it in 12 quarters.
Brown Brothers Harriman & Co's Stealth BioTherapeutics Corp. ADS position peaked at $570K in Q4 2019.
0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on Brown Brothers Harriman & Co's 13F filing for Q4 2022, filed 9 Feb 2023.